Urbana, Illinois Clinical Trials

A listing of Urbana, Illinois clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 201 clinical trials
featured
ECOSPOR III: A Phase 3 Multicenter, RandomizeEd, Double Blind, Placebo COntrolled, Parallel Group Study to Evaluate the Safety, Tolerability, & Efficacy of SER-109 vs. Placebo to Reduce Recurrence of ClOstRidium Difficile Infection (CDI) in Adults

ECOSPOR III is a Phase 3, multicenter, randomized, double-blind, placebo-controlled, parallel-group study of the safety, tolerability, and efficacy of SER-109 versus placebo in adult subjects 18 years of age or older with recurrent CDI, defined as: a history of ≥ 3 CDI episodes within 9 months, inclusive of the current …

antibiotics
antibiotic therapy
vancomycin
clostridium difficile
fidaxomicin
Carle Foundation Hospital
 (0.2 away) Contact site
  • 1092 views
  • 21 Dec, 2020
  • +71 other locations
featured
A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Locally Advanced/Metastatic or Surgically Unresectable Solid Tumor Malignancies Harboring Activating FGFR Mutations or Translocations (FIGHT-207)

The purpose of this study is to evaluate the efficacy and safety of pemigatinib in participants with previously treated locally advanced/metastatic or surgically unresectable solid tumor malignancies harboring activating FGFR mutations or translocations.  

malignancies
primary cancer
FGFR3
solid tumors
cancer
Carle Cancer Center
 (0.3 away) Contact site
  • 46 views
  • 14 Dec, 2020
  • +61 other locations
featured
Lung Cancer/Pulmonary Nodules – Blood Sample

Lung Cancer/Pulmonary Nodules – Blood Sample

PMG Research of Christie Clinic
 (1.8 away) Contact site
  • 108 views
  • 23 Nov, 2020
  • 1 location
featured
LUCY Study - Abdominal Aortic Aneurysm Repair

LUCY Study - Abdominal Aortic Aneurysm Repair

PMG Research of Christie Clinic
 (1.8 away) Contact site
  • 390 views
  • 23 Nov, 2020
  • 1 location
featured
Type 2 Diabetes with Cardiovascular Risk – Ages 40+

Type 2 Diabetes with Cardiovascular Risk – Ages 40+

PMG Research of Christie Clinic
 (1.8 away) Contact site
  • 250 views
  • 25 Mar, 2021
  • 1 location
featured
Advanced Colorectal or Lung Cancer Screening

Advanced Colorectal or Lung Cancer Screening

PMG Research of Christie Clinic
 (1.8 away) Contact site
  • 158 views
  • 25 Mar, 2021
  • 1 location
featured
Chronic Heart Failure – Ages 18-85

Chronic Heart Failure – Ages 18-85

PMG Research of Christie Clinic
 (1.8 away) Contact site
  • 158 views
  • 25 Mar, 2021
  • 1 location
Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer

This randomized phase III trial studies how well stereotactic body radiation therapy works compared to intensity-modulated radiation therapy in treating patients with stage IIA-B prostate cancer. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. Stereotactic body radiation therapy is a specialized radiation therapy that sends …

Carle Cancer Center
 (0.2 away) Contact site
  • 934 views
  • 12 Jun, 2021
  • +178 other locations
LUMINA Phase III Study Assessing the Efficacy and Safety of Intravitreal Injections of 440 ug DE-109 Sirolimus for the Treatment of Active Non-Infectious Uveitis of the Posterior Segment of the Eye

This is a Phase III study to assess the efficacy and safety of DE-109 440 g every 2 months in subjects with active, non-infectious uveitis of the posterior segment of the eye (NIU-PS). There is a 6-month, single-arm, open-label period after completion of the 6-month doublemasked, controlled period allows the …

Carle Foundation Hospital
 (0.2 away) Contact site
  • 126 views
  • 01 Aug, 2021
  • +89 other locations
Efficacy and Safety of Pemigatinib in Previously Treated Locally Advanced/Metastatic or Surgically Unresectable Solid Tumor Malignancies Harboring Activating FGFR Mutations or Translocations (FIGHT-207)

The purpose of this study is to evaluate the efficacy and safety of pemigatinib in participants with previously treated locally advanced/metastatic or surgically unresectable solid tumor malignancies harboring activating FGFR mutations or translocations.

Carle Cancer Center
 (0.4 away) Contact site
  • 50 views
  • 01 Aug, 2021
  • +122 other locations